Pain News and Research

Latest Pain News and Research

Researchers identify gene responsible for malfunctions in fear-related memory system

A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.

29 Nov 2013

CPCs not powerful enough to be used as a single tool in diagnosis of acute myocardial infarction

Using chest pain characteristics (CPCs) specific to women in the early diagnosis of acute myocardial infarction (AMI, heart attack) in the emergency department does not seem to be supported by the findings of a study published by JAMA Internal Medicine, a JAMA Network publication.

27 Nov 2013

Caregivers selected to receive the 2013 Shire BRAVE Awards

Selflessness, determination, courage and hope. These are among the qualities that describe the eighteen caregivers from around the world who have been selected as recipients of the 2013 Shire BRAVE Awards, an international program that honors the bravery and devotion of non-professional carers.

27 Nov 2013

Novel micro-catheter fluorescent dye method to treat aneurysm in deep brain

In March 2013, Eric Wagner told his wife to call 9-1-1 because he was feeling the worst that he had ever felt. He was rushed by EMS to University Hospitals (UH) Ahuja Medical Center, and then airlifted to UH Case Medical Center, where brain scans showed that he had a ruptured aneurysm, a leaking blister on a blood vessel that was letting blood flow into his brain and causing a stroke.

27 Nov 2013

Drug interactions impact use of cholesterol-lowering statin drugs

A new study has found that many people who stopped taking cholesterol-lowering statin drugs were also taking an average of three other drugs that interfered with the normal metabolism of the statins.

27 Nov 2013

Customized palliative care can reduce health care costs, improve care for high-risk geriatric patients

For high-risk geriatric patients, improved palliative care that is matched to their changing needs at home can reduce emergency room visits, reduce health care costs, and improve overall care. Current gaps in policy and practice that block implementation of these beneficial customized care models are presented in the article "Research Priorities in Geriatric Palliative Care: Policy Initiatives," published in Journal of Palliative Medicine, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

27 Nov 2013

Bioxodes completes seed funding round to bring Ir-CPI product into pre-clinical development

Bioxodes SA, a company developing products derived from natural sources, has completed a EUR 2.6 million (USD 3.5 million) first seed funding round with a consortium of business angels and Belgian investment funds. EUR 1.6 million is from the European Regional Development Fund and the Walloon Region in Belgium via the Retech program for Research and Technology. It will be used to bring the company’s lead product Ir-CPI into pre-clinical development over the next 18 months.

27 Nov 2013

FDA accepts Purdue Pharma's Targiniq ER Tablets CII NDA for review

Purdue Pharma L.P. today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application for Targiniq ER (oxycodone HCl/naloxone HCl controlled-release) Tablets CII, for the management of chronic pain.

27 Nov 2013

Researchers find that hay fever and allergies make migraines worse

People with migraine who also battle allergies and hay fever (rhinitis) endure a more severe form of headaches than their peers who struggle with migraine, but aren't affected by the seasonal or year-round sniffles, according to researchers from the University of Cincinnati, Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University and Vedanta Research.

26 Nov 2013

QRxPharma refiles MOXDUO New Drug Application with US FDA

QRxPharma Limited announced today that the Company resubmitted its MOXDUO New Drug Application. At a meeting in early October, the United States Food and Drug Administration provided QRxPharma with guidance on its requirements for the NDA refiling as well as data validation documentation.

26 Nov 2013

Lockheed Martin donates funds to new telehealth suite dedicated for wounded warriors

Thanks to a $4 million gift from Lockheed Martin, UCLA Health System's Operation Mend now has a state-of-the-art telehealth suite, which will enable improved communication between the program's personnel, patients and partners, and a renovated recovery area for the wounded warriors who undergo surgery at the Westwood facility.

26 Nov 2013

Study defines HRV reference values for children

Measurement of heart rate variability (HRV) is a useful method when assessing the role of the nervous system for heart function. Standard reference values for heart rate variability in adults have existed for a long time already, but similar values have not been available for children until now.

26 Nov 2013

More adults are undergoing minimally invasive surgery for diseased kidneys

More children, like adults, are undergoing minimally invasive surgery for diseased kidneys, with most of the procedures being performed at teaching hospitals to treat non-cancerous conditions.

26 Nov 2013

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency's: Committee for Medicinal Products for Human Use has adopted a positive opinion for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.

25 Nov 2013

Radiation therapy now available via latest version of ACR ppropriateness Criteria

New and updated evidence-based guidelines to help health care providers choose the most appropriate medical imaging exam or radiation therapy for a patient's clinical condition are now available via the latest version of the American College of Radiology (ACR) Appropriateness Criteria.

25 Nov 2013

Patients with symptom clusters after surgery for esophageal cancer have increased mortality risk

A new study has found that several months after surgery for esophageal cancer, different symptoms cluster together in different types of patients. In addition, patients with certain symptom clusters have an increased risk of dying from their disease.

25 Nov 2013

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

Bayer HealthCare and Onyx Pharmaceuticals, Inc., an Amgen subsidiary, today announced that the U.S. Food and Drug Administration has approved a supplemental New Drug Application for the oral multi-kinase inhibitor NEXAVAR (sorafenib) tablets for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment.

23 Nov 2013

EYLEA Injection gets approval in Japan for treatment of macular edema following CRVO

Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.

22 Nov 2013

First molecular test developed to detect eosinophilic esophagitis

Researchers at Cincinnati Children's Hospital Medical Center have developed the first molecular test to diagnose eosinophilic esophagitis, a chronic upper gastrointestinal disorder. The incidence of EoE has skyrocketed since it was first characterized two decades ago.

22 Nov 2013

Study finds that anticipation of pain worse than pain itself

Faced with inevitable pain, most people would choose to get it out of the way as soon as possible, according to a new study.

22 Nov 2013

Pain News and Research

Latest Pain News and Research

Researchers identify gene responsible for malfunctions in fear-related memory system

CPCs not powerful enough to be used as a single tool in diagnosis of acute myocardial infarction

Caregivers selected to receive the 2013 Shire BRAVE Awards

Novel micro-catheter fluorescent dye method to treat aneurysm in deep brain

Drug interactions impact use of cholesterol-lowering statin drugs

Customized palliative care can reduce health care costs, improve care for high-risk geriatric patients

Bioxodes completes seed funding round to bring Ir-CPI product into pre-clinical development

FDA accepts Purdue Pharma's Targiniq ER Tablets CII NDA for review

Researchers find that hay fever and allergies make migraines worse

QRxPharma refiles MOXDUO New Drug Application with US FDA

Lockheed Martin donates funds to new telehealth suite dedicated for wounded warriors

Study defines HRV reference values for children

More adults are undergoing minimally invasive surgery for diseased kidneys

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Radiation therapy now available via latest version of ACR ppropriateness Criteria

Patients with symptom clusters after surgery for esophageal cancer have increased mortality risk

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

EYLEA Injection gets approval in Japan for treatment of macular edema following CRVO

First molecular test developed to detect eosinophilic esophagitis

Study finds that anticipation of pain worse than pain itself

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Pain News and Research

Latest Pain News and Research

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Newsletters you may be interested in